Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
10/24/2000 | US6136560 Amidotransferase, ratB, of streptococcus pneumoniae |
10/24/2000 | US6136557 Strepococcus pneumoniae gene sequence FtsH |
10/24/2000 | US6136553 Computer based method for identifying amino acid sites which affect stability of the target protein |
10/24/2000 | CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv) |
10/24/2000 | CA2065439C Expression of herbicide metobolizing cytochromes p450 |
10/24/2000 | CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression |
10/20/2000 | CA2306355A1 Methods and compositions for treating human cells |
10/19/2000 | WO2000061813A1 A second mammalian tankyrase |
10/19/2000 | WO2000061810A1 Antisense oligonucleotides comprising universal and/or degenerate bases |
10/19/2000 | WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
10/19/2000 | WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
10/19/2000 | WO2000061787A2 gyrA |
10/19/2000 | WO2000061785A2 Polynucleotide and polypeptide sequences of monkey cathepsin k |
10/19/2000 | WO2000061781A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents |
10/19/2000 | WO2000061780A1 Compositions and methods for extending life span |
10/19/2000 | WO2000061778A1 Staphylococcus aureus mvaa |
10/19/2000 | WO2000061776A1 Vitamin d derivatives and process for producing the same |
10/19/2000 | WO2000061771A2 Transgenic plants containing altered levels of sterol compounds and tocopherols |
10/19/2000 | WO2000061769A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS |
10/19/2000 | WO2000061768A2 Preparation of biologically active molecules |
10/19/2000 | WO2000061767A1 Extracellular protease from $i(acremonium chrysogenum) with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin |
10/19/2000 | WO2000061766A2 Telomerase-specific cancer vaccine |
10/19/2000 | WO2000061765A2 Lipoxygenase proteins and polynucleotides encoding the same |
10/19/2000 | WO2000061764A1 Carotene hydroxylase and method for producing xanthophyll derivatives |
10/19/2000 | WO2000061763A2 Proteins related to gaba metabolism |
10/19/2000 | WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
10/19/2000 | WO2000061734A2 Enzyme compositions and their use as catalysts |
10/19/2000 | WO2000061733A1 Xylose isomerase with improved properties |
10/19/2000 | WO2000061732A1 α-GLYCATED AMINO ACID RELEASING ENZYME |
10/19/2000 | WO2000061731A2 Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
10/19/2000 | WO2000061730A1 Glucose dehydrogenase |
10/19/2000 | WO2000061728A2 Human elastase i |
10/19/2000 | WO2000061727A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use |
10/19/2000 | WO2000061723A1 L-amino acid-producing bacteria and process for producing l-amino acid |
10/19/2000 | WO2000061721A1 Method for obtaining $i(a. niger) cultures and their uses for producing ferulic acid and vanillic acid |
10/19/2000 | WO2000061622A2 Genes associated with diseases of the kidney |
10/19/2000 | WO2000061617A2 Transiently immortalized cells for use in gene therapy |
10/19/2000 | WO2000061609A2 Prodrugs of thrombin inhibitors |
10/19/2000 | WO2000061608A2 Low-molecular inhibitors of complement proteases |
10/19/2000 | WO2000061577A1 Prodrugs of thrombin inhibitors |
10/19/2000 | WO2000061542A1 Caspase inhibitors and the use thereof |
10/19/2000 | WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
10/19/2000 | WO2000061180A2 Products and methods for treating ptp lar related diseases |
10/19/2000 | WO2000061179A1 Kringle domains of plasminogen, capable of modulating angiogenesis in vivo |
10/19/2000 | WO2000060933A1 Pkc induced targets |
10/19/2000 | WO2000039779A3 Hinge structure |
10/19/2000 | WO2000039290A8 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
10/19/2000 | WO2000034485A3 Beta-1,3-galactosyltransferase homologs |
10/19/2000 | WO2000032793A3 Plant cell derived diacylglycerol acyltransferases |
10/19/2000 | WO2000028008B1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
10/19/2000 | WO2000012720A8 Elongase genes and uses thereof |
10/19/2000 | WO1999067381A9 Treatment of staphylococcus infections |
10/19/2000 | DE19916929A1 New oligonucleotide primers, useful for amplifying human telomerase RNA for diagnosis, prognosis and monitoring of cancer |
10/19/2000 | DE19916242A1 PSA-haltige Substanz und deren Verwendung PSA-containing substance and its use |
10/19/2000 | DE19915938A1 Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung Production of pancreatic procarboxypeptidase B isoforms and its muteins and their use |
10/19/2000 | CA2372120A1 Transgenic plants containing altered levels of sterol compounds and tocopherols |
10/19/2000 | CA2370267A1 Prodrugs of thrombin inhibitors |
10/19/2000 | CA2370114A1 Method for obtaining a. niger cultures and their uses for producing ferulic acid and vanillic acid |
10/19/2000 | CA2369996A1 Compositions and methods for extending life span |
10/19/2000 | CA2369827A1 Separation of plasma components |
10/19/2000 | CA2369619A1 Caspase inhibitors and the use thereof |
10/19/2000 | CA2369378A1 Low-molecular inhibitors of complement proteases |
10/19/2000 | CA2368953A1 Proteins related to gaba metabolism |
10/19/2000 | CA2368830A1 Prodrugs of thrombin inhibitors |
10/19/2000 | CA2366671A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
10/19/2000 | CA2365984A1 Antisense oligonucleotides comprising universal and/or degenerate bases |
10/19/2000 | CA2365945A1 Products and methods for treating ptp lar related diseases |
10/19/2000 | CA2365919A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents |
10/19/2000 | CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same |
10/19/2000 | CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
10/19/2000 | CA2365906A1 Carotene hydroxylase and method for producing xanthophyll derivatives |
10/19/2000 | CA2365901A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
10/19/2000 | CA2364565A1 Glucose dehydrogenases |
10/19/2000 | CA2364541A1 Genes associated with diseases of the kidney |
10/19/2000 | CA2360318A1 A second mammalian tankyrase |
10/18/2000 | EP1045250A1 A global test for evaluating the functionality of the thrombin/antithrombin system |
10/18/2000 | EP1045028A1 Deoxyribonucleases |
10/18/2000 | EP1045027A1 Novel gene having reverse transcriptase motif |
10/18/2000 | EP1045026A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding |
10/18/2000 | EP1045025A1 (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE |
10/18/2000 | EP1044278A1 Biosynthesis of medium chain length polyhydroxyalkanoates |
10/18/2000 | EP1044277A2 Recombinant, active caspases and uses thereof |
10/18/2000 | EP1044276A2 Proteases from gram positive organisms |
10/18/2000 | EP1044275A1 Mammalian matrix-type metalloprotease |
10/18/2000 | EP1044264A2 Branched chain amino acid biosynthetic enzymes |
10/18/2000 | EP0467932B1 Urokinase-type plasminogen activator receptor |
10/18/2000 | CN1270636A DNA sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants |
10/18/2000 | CN1270634A Vertebrate telomerase genes and proteins and uses thereof |
10/18/2000 | CN1270224A DNA molecules of aminopeptidase with new code and production of the aminopeptidase |
10/18/2000 | CN1270223A Method for producing L-argenine and synthesising emzyme gene by carbamyl phosphoric acid of corynebacterium |
10/18/2000 | CN1057568C Process for preparation of D-alpha-amino acids |
10/18/2000 | CN1057533C Method for producing clostridium perfringers vaccines |
10/17/2000 | US6133506 Keto-acyl-(ACP) reductase promoter from cuphea lanceolata |
10/17/2000 | US6133505 Phytopathogenic geminivirus resistant transgenic plants and seeds and methods for obtaining same by introduction of mutated C1 gene |
10/17/2000 | US6133504 Transgenic plant tolerant to sodium chloride stress containing a foreign dna encoding a gene for reductase enzyme operably linked to a heterologous promoter |
10/17/2000 | US6133438 Alkylating unblocked cytidine to form 2'-o-alkylated cytidine, blocking the 5'-hydroxyl moiety, and phosphitylating the 3'-position |
10/17/2000 | US6133421 Polypeptides and polypeptide subunits of a stereospecific nitrile hydratase enzyme |
10/17/2000 | US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
10/17/2000 | US6133417 Enzyme catalyzes conversion of amino acid to corresponding n-hydroxyamino acid and then into corresponding oxime; for transgenic plants resistant to insects, acarids, or nematodes or plants with improved nutritive value |
10/17/2000 | US6133416 Inhibition of cell growth by an anti-proliferative factor |